Sivik Global Healthcare’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.58M Hold
30,000
1.96% 28
2026
Q1
$2.58M Sell
30,000
-10,000
-25% -$898K 1.96% 28
2025
Q4
$3.49M Buy
+40,000
New +$3.04M 1.01% 38
2023
Q1
Sell
-37,745
Closed -$2.8M 42
2022
Q4
$2.8M Buy
+37,745
New +$2.57M 1.32% 33
2022
Q2
Sell
-65,000
Closed -$4.8M 45
2022
Q1
$4.8M Sell
65,000
-10,000
-13% -$695K 1.98% 25
2021
Q4
$5.42M Sell
75,000
-20,000
-21% -$1.45M 2.32% 21
2021
Q3
$7.28M Buy
95,000
+40,000
+73% +$3.21M 1.74% 23
2021
Q2
$4.26M Sell
55,000
-10,000
-15% -$711K 0.83% 34
2021
Q1
$4.01M Buy
+65,000
New +$4.12M 1.46% 33
2017
Q3
Sell
-77,340
Closed -$2.56M 79
2017
Q2
$2.56M Buy
+77,340
New +$2.43M 0.94% 45
2015
Q1
Sell
-71,900
Closed -$1.71M 76
2014
Q4
$1.71M Buy
+71,900
New +$1.59M 0.69% 60
2014
Q3
Sell
-49,538
Closed -$1.19M 74
2014
Q2
$1.19M Hold
49,538
0.6% 61
2014
Q1
$1.32M Buy
+49,538
New +$1.18M 0.82% 53

Other funds holding GMED

Sivik Global Healthcare's GMED Position: Q2 2026 in Review

Sivik Global Healthcare held its Globus Medical (GMED) position steady in Q2 2026 at 30,000 shares worth $2.58M. The position accounts for 1.96% of the portfolio, ranked #28.

Sivik Global Healthcare first reported a position in GMED in Q1 2014 and has held it in 13 quarters since. The position peaked at $7.28M in Q3 2021. 161 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Sivik Global Healthcare held 30,000 shares of Globus Medical worth $2.58M as of Q2 2026.
  • Sivik Global Healthcare left its Globus Medical share count unchanged in Q2 2026.
  • Globus Medical made up 1.96% of Sivik Global Healthcare's portfolio in Q2 2026, its #28 holding.
  • Sivik Global Healthcare first reported a position in Globus Medical in Q1 2014 and has held it in 13 quarters since.
  • Sivik Global Healthcare's Globus Medical position peaked at $7.28M in Q3 2021.
  • 161 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Sivik Global Healthcare's 13F filing for Q2 2026, filed 20 Jul 2026.